Sep 17, 2020 | Webinar

Invitation to webinar on NMIBC follow-up

Nucleix, Israel and Oncotest-Rhenium, Israel are pleased to invite you to the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”, led by Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands.

The webinar will discuss follow-up of Non-Muscle-Invasive Bladder Cancer (NMIBC) and the position of urine biomarkers, and will be held in English.

Time: Thursday, 24 September 2020, from 20.00-21.00 PM Israeli time / 19.00-20.00 PM CEST.

The webinar will start with a 45 minutes lecture, and the last 15 minutes will be dedicated to a Q&A session.

Registration is free: https://zoom.us/meeting/register/tJcpdeCvqDojHdXOndQdiOUqVK7nZd6Uj_sF

If you are unable to attend, the webinar will be recorded and will become available on this platform afterwards.

Other updates

Urinary biomarkers for the surveillance of NMIBC

Can urinary biomarkers help address some of the key limitations of cystoscopy and urine cytology in the surveillance of non-muscle-invasive bladder cancer (NMIBC)? Watch this expert presentation to discover how urinary biomarkers may support a more patient-centred and...

read more